UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by First Manhattan CO. LLC.

First Manhattan CO. LLC. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,522,998 shares of the healthcare conglomerate's stock after selling 34,421 shares during the period. UnitedHealth Group comprises approximately 2.3% of First Manhattan CO. LLC.'s investment portfolio, making the stock its 9th largest holding. First Manhattan CO. LLC. owned 0.17% of UnitedHealth Group worth $770,550,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. NewSquare Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group in the 4th quarter worth about $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at $28,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

UNH stock traded down $4.83 during mid-day trading on Friday, reaching $380.72. The company had a trading volume of 8,371,190 shares, compared to its average volume of 4,716,091. The stock has a market capitalization of $346.54 billion, a P/E ratio of 24.56, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock's 50-day simple moving average is $488.01 and its two-hundred day simple moving average is $522.31. UnitedHealth Group Incorporated has a one year low of $378.54 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the business earned $6.91 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 2.21%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is presently 35.18%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. HSBC restated a "hold" rating and set a $490.00 price objective on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Truist Financial lowered their price target on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a report on Monday, April 21st. Oppenheimer reduced their target price on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a report on Monday, April 21st. Finally, JPMorgan Chase & Co. decreased their price objective on shares of UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Four research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $596.86.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.